Group 1 - The core viewpoint of the article highlights that the medical device sector is experiencing a performance turning point due to the optimization of procurement policies, continuous improvement in equipment bidding data, and a gradual decrease in channel inventory [1] - The high-value consumables segment is expected to see valuation and performance recovery under the backdrop of ongoing optimization of procurement policies [1] - There is optimism regarding the international expansion of domestic medical device companies, which are anticipated to undergo valuation reshaping due to their long-term growth potential in international markets [1] Group 2 - The article emphasizes investment opportunities in technological innovation within the medical device sector, particularly in areas such as AI in healthcare, brain-computer interfaces, surgical robots, and exoskeleton robots, which are expected to attract investor attention [1]

Group 1 - The core viewpoint of the report is that A-shares are expected to see significant incremental capital by 2026, which may sustain a slow bull market [1] - The first quarter is identified as a peak period for the maturity of time deposits, suggesting that funds may flow from insurance and wealth management channels into the equity market, marking the most abundant time for incremental capital throughout the year [1] - Long-term and medium-term funds are projected to account for about one-third of total capital inflows, becoming a key foundation for micro liquidity in A-shares [1] Group 2 - Public and private equity funds are expected to be the two major areas of marginal improvement, with their allocation preferences potentially influencing market style performance [1] - The main market contradiction in 2026 is anticipated to shift towards verifying economic prosperity and achieving performance results, with long-term funds providing a safety net [1] - Active funds such as public and private equity are likely to further strengthen the dual main line market trend of "technology + resource products," while sector rotation may accelerate [1]

Core Viewpoint - The A-share market is expected to welcome a significant amount of incremental funds in 2026, which may sustain a slow bull market. The first quarter is projected to be the peak period for the maturity of fixed deposits, with funds likely flowing from insurance and wealth management channels into the equity market, marking the most abundant time for incremental funds throughout the year [3][4][62]. Group 1: Incremental Funds Sources - Incremental funds are primarily sourced from the migration of household deposits and pressures from asset scarcity, with insurance premium income continuing to grow significantly. By Q3 2025, the equity allocation ratio is expected to rise to 15.5%, nearing historical highs, which could release over 840 billion yuan into the market [4][6][66]. - The total amount of fixed deposits maturing in 2026 is estimated to be around 45 trillion yuan, which will likely lead to increased allocations in wealth management and "fixed income+" products, contributing over 900 billion yuan in medium to long-term funds to the A-share market [4][14][17]. - Public funds are expected to see a net inflow of approximately 230 billion yuan in 2026, driven by the recovery of fund net values and the enhanced motivation of individual investors to enter the market [4][33][34]. Group 2: Market Dynamics - The market's main contradictions in 2026 will shift towards verifying economic prosperity and performance realization, with medium to long-term funds providing a safety net. Active funds from public and private sectors are anticipated to further strengthen the "technology + resource products" dual mainline market, with accelerated sector rotation [4][62][64]. - The "national team" funds are expected to see a significant reduction in inflows, with a projected net inflow of about 200 billion yuan in 2026, as their role shifts in a bull market environment [19][22][23]. - High-risk funds, represented by margin trading and private equity, are expected to remain active, with margin trading net inflows estimated at around 450 billion yuan and private equity assets projected to grow to 8.5 trillion yuan, contributing approximately 700 billion yuan in incremental funds [4][26][31]. Group 3: Global and Domestic Influences - Overseas funds are anticipated to strategically allocate to Chinese assets, with northbound capital expected to net inflow around 100 billion yuan in 2026, although this impact on the overall market is expected to be limited [4][36][39]. - The macro liquidity environment is favorable, with a global interest rate cut cycle entering its later stages, but the marginal improvement in policies is expected to gradually converge. The micro-funding situation is likely to improve significantly, supporting a strong performance in equities over fixed income [4][45][49].

Core Viewpoint - The medical device sector is experiencing a performance turning point due to optimized procurement policies, improved bidding data, and decreasing channel inventory, particularly in the high-value consumables segment, which is expected to see valuation and performance recovery [1][7]. Group 1: Procurement Policy Updates - The sixth batch of national high-value medical consumables procurement was opened on January 13, with 12 types of consumables included, resulting in 440 products from 202 companies being selected out of 496 bids from 227 companies [2][3]. - The procurement process aims to ensure clinical continuity and quality by grouping products based on demand and supply capabilities, allowing for more competitive pricing strategies [4][6]. - Special product functionalities are considered in the procurement process, allowing for differentiated pricing based on clinical value and innovation [5]. Group 2: Market Outlook - The high-value consumables segment is expected to see a performance turning point by 2026, particularly in areas like electrophysiology, peripheral intervention, urology, and cardiovascular intervention, as the effects of procurement policies take hold [7]. - There is optimism regarding the international expansion of domestic medical device companies, with expectations that international business will surpass domestic growth, leading to valuation re-evaluation for companies with significant overseas operations [1][7]. - Investment opportunities in technological innovation within the medical device sector are anticipated, with emerging areas such as AI healthcare, brain-computer interfaces, surgical robots, and exoskeleton robots likely to attract investor attention [1][7].

Core Viewpoint - The report from CITIC Securities indicates that A-shares are expected to see significant incremental capital in 2026, potentially sustaining a slow bull market [1][5] Group 1: Long-term Capital - Long-term capital is identified as a core source of incremental funds, with insurance premium income continuing to grow significantly, leading to an increase in equity allocation to 15.5% by Q3 2025, close to historical highs [2] - The combination of insurance and wealth management channels is expected to contribute over 900 billion yuan in long-term capital to the market in 2026 [2] Group 2: Public Fund Capital - The pressure for fund redemptions is believed to have passed, with public funds benefiting from net asset value recovery and a positive investment sentiment, leading to an expected net inflow of 230 billion yuan in 2026, primarily from passive funds [3] Group 3: Other Funding Channels - "National team" funds are expected to see a significant slowdown in inflows, with a projected net inflow of about 20 billion yuan in 2026, while ETFs are becoming the main allocation channel [4] - Margin trading and private equity funds remain active, with expected net inflows of 450 billion yuan from margin trading and a projected increase in private equity scale to 8.5 trillion yuan, contributing around 700 billion yuan in incremental funds [4] - Foreign capital is entering a "4.0 era," with global funds expected to strategically allocate to Chinese assets, anticipating a net inflow of about 100 billion yuan from northbound capital [4] Group 4: Market Focus in 2026 - The focus of the market in 2026 will shift towards verifying economic conditions and performance realization, with long-term capital providing a safety net and active funds reinforcing a "technology + resource" dual mainline market trend [5] - The current hot sectors in A-shares are awaiting performance realization, with thematic concepts and rebound sectors showing significant elasticity [5]

Core Viewpoint - The company, Softstone Information Technology (Group) Co., Ltd., has announced a change in its continuous supervision sponsor representative for its initial public offering (IPO) on the Shenzhen Stock Exchange's ChiNext board [1]. Group 1 - The company received a letter from CITIC Jianzhong Securities regarding the change of its continuous supervision sponsor representative [1]. - CITIC Jianzhong was originally represented by Huang Yaying and Xu Jie as the continuous supervision sponsor representatives for the company's IPO [1]. - Huang Yaying will no longer serve in this role due to personal work adjustments, and Chen Zehao has been appointed to take over the responsibilities [1].

Core Insights - The "2026 Global and China Capital Market Outlook Forum and the Golden Unicorn Best Wealth Management Institution and Best Investment Advisor Ceremony" will be held on January 15, 2026, featuring top experts and thought leaders discussing macro ecology, market strategies, and investment outlooks for 2026 [1] Group 1 - The event will unveil the honors for the 2025 Golden Unicorn Best Wealth Management Institution [1] - The forum aims to outline a comprehensive blueprint for the prospects of 2026 from multiple dimensions [1] - The event will also recognize the 2025 Golden Unicorn Annual Best Financial Technology Empowerment Award winners [1]

专题：2026全球与中国资本市场展望论坛 专题：2026全球与中国资本市场展望论坛 2026年1月15日，"2026全球与中国资本市场展望论坛暨金麒麟最佳财富管理机构、最佳投资顾问盛 典"举办，论坛邀请了多位顶尖专家与思想领袖，他们从宏观生态、市场策略与投资展望等多个维度， 为我们勾勒2026年的前景蓝图。 同时，会议隆重揭晓了2025金麒麟最佳财富管理机构荣誉。 2026年1月15日，"2026全球与中国资本市场展望论坛暨金麒麟最佳财富管理机构、最佳投资顾问盛 典"举办，论坛邀请了多位顶尖专家与思想领袖，他们从宏观生态、市场策略与投资展望等多个维度， 为我们勾勒2026年的前景蓝图。 同时，会议隆重揭晓了2025金麒麟最佳财富管理机构荣誉。 新浪财经2025金麒麟·年度最佳全域流量运营先锋奖荣誉榜如下： 随着新"国九条"政策落地，财富管理能力从"加分项"跃升为券商高质量发展的"必答题"。聚焦主业、服 务居民财富增长，已成为行业核心使命。 在此背景下，新浪财经举办2025金麒麟最佳财富管理机构评选。本届评选全面升级，设八大奖项，旨在 从综合实力、成长动能、科技赋能与生态构建等多维度，全景扫描券商财富管理业务的 ...

Core Insights - The fundamental driver of AI power supply solutions is the continuous improvement in single-chip and single-cabinet power levels, with companies like NVIDIA leading the charge in upgrading their AI chips [1] - The power of AI data centers in North America is projected to reach 71GW by 2028, driven by advancements in multi-chip designs such as NVL72 from NVIDIA and Superpod from Google [1] Group 1: Power Supply Evolution - The main directions for AIDC power supply iteration are high power, high voltage, and direct current, with NVIDIA's white paper outlining a clear path from AC to 800V DC solutions [2] - The OCP organization has established ±400V power supply standards, aiming for MW-level cabinet power through direct current supply [2] Group 2: Technological Changes and Growth - The evolution of power supply solutions has led to the development of integrated devices like HVDC Sidecar and SST hosts, which can perform multiple functions such as voltage reduction and power quality improvement [3] - Key challenges in R&D include power conversion modules and high-frequency isolation transformers, with third-generation wide bandgap semiconductors like SiC and GaN being crucial for achieving high voltage and efficiency [3] Group 3: Investment Opportunities - Four key areas for investment consideration include AIDC power hosts (PSU, HVDC, SST), with companies like Sungrow Power (300274.SZ) and Megmeet (002851.SZ) being notable mentions [4] - Energy storage solutions at the station level are highlighted, with companies such as Sungrow Power and Fluence Energy (FLNC.US) being potential investment targets [4] - Core incremental components like solid-state circuit breakers and electronic fuses are also identified, with companies like Liyang Technology (002706.SZ) and Vicor Corporation (VICR.US) being recommended [4] - Third-generation semiconductors like GaN and SiC are emphasized as critical components for future developments [4]

1月15日，建科智能装备制造(天津)股份有限公司（以下简称"建科智能"）以现场调研形式接待了中信 建投证券的特定对象调研。公司副总经理、董事会秘书林琳出席并与投资者就公司主营业务、研发团队 激励机制及核电项目应用等核心议题展开深入交流。作为钢筋加工装备行业首家上市公司及领军企业， 建科智能在智能化钢筋加工机器人装备领域的技术实力、市场布局及应用案例成为本次调研焦点。 调研基本情况 本次投资者关系活动类别为特定对象调研，于2026年1月15日（周四）上午10:00-11:30在天津市北辰区 陆路港物流装备产业园陆港五纬路7号（建科智能厂内）举行。参与单位为中信建投证券，参与人员包 括王翔、于文慧；上市公司接待人员为副总经理、董事会秘书林琳。 公司概况：深耕行业二十余年 引领智能化钢筋加工装备发展 林琳在调研中介绍，建科智能成立于2002年，深耕智能化钢筋加工机器人装备行业二十余年，目前已发 展成为国内最大、全球前列的智能化钢筋加工机器人装备企业之一，同时也是该行业首家上市公司。公 司专注于各类智能化中高端数控钢筋加工机器人装备及配套软件的研发、设计、生产和销售，并提供钢 筋加工智能工厂整体解决方案，产品广泛应用 ...